STOCKHOLDERS' DEFICIT	3 Months Ended
Mar. 31, 2020
Stockholders Equity Note [Abstract]
STOCKHOLDERS' DEFICIT	13. STOCKHOLDERS' DEFICIT At March 31, 2020, the Company's Board of Directors had the authority to issue 200,000,000 shares of stock, of which 190,000,000 were designated as Common Stock, with a par value of $0.00005 per share, and 10,000,000 were designated as Preferred Stock, with a par value of $0.001 per share. At March 31, 2020, the Company had shares of common stock issued of 25,580,107 and shares of common stock outstanding of 24,580,107. In the first quarter of 2020, the Company issued 67,540 shares of unrestricted common stock in settlement of a previously accrued cash bonus liability; resulting in the reclassification of $1.3 million to additional paid-in capital. In the first quarter of 2019, the Company issued 36,776 shares of unrestricted common stock in settlement of a previously accrued cash bonus liability; resulting in the reclassification of $0.6 million to additional paid-in capital.

STOCKHOLDERS' DEFICIT

3 Months Ended

Mar. 31, 2020

13. STOCKHOLDERS' DEFICIT

At March 31, 2020, the Company's Board of Directors had the authority to issue 200,000,000 shares of stock, of which 190,000,000 were designated as Common Stock, with a par value of $0.00005 per share, and 10,000,000 were designated as Preferred Stock, with a par value of $0.001 per share. At March 31, 2020, the Company had shares of common stock issued of 25,580,107 and shares of common stock outstanding of 24,580,107.

In the first quarter of 2020, the Company issued 67,540 shares of unrestricted common stock in settlement of a previously accrued cash bonus liability; resulting in the reclassification of $1.3 million to additional paid-in capital. In the first quarter of 2019, the Company issued 36,776 shares of unrestricted common stock in settlement of a previously accrued cash bonus liability; resulting in the reclassification of $0.6 million to additional paid-in capital.